Reply  by Shave, Rob et al.
R1
2
P
o
P
b
t
r
d
a
p
b
a
s
i
p
t
a
p
b
(
(
s
p
T
d
(
i
p
(
d
p
p
d
c
r
i
f
s
s
i
t
s
i
c
(
i
d
o
*
W
*
A
L
A
A
A
E
R
1
2
3
4
5
6
7
8
9
R
W
s
a
d
p
s
n
T
p
e
c
l
H
p
l
m
I
c
1341JACC Vol. 53, No. 15, 2009 Correspondence
April 14, 2009:1339–42EFERENCES
. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal
syndrome. J Am Coll Cardiol 2008;52:1527–39.
. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The
severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J
2005;26:11–7.Letters to the Editor
ost-Exercise Release
f Cardiac Troponins
ost-exercise release of cardiac troponin (cTn)T and cTnI has
een previously reported after prolonged strenuous exercise (1). Up
o now, it has been unclear whether post-exercise release of cTn
epresents necrosis of cardiac myocytes and thus irreversible
amage or a transient and reversible change in membrane perme-
bility of the myocyte (1). Similarly, whether the substrate for
ost-exercise release of cTn is physiologic or pathologic has not
een determined (1).
Middleton et al. (2) examined the kinetics of cTnT during and
fter completion of a marathon on a motorized treadmill. They
uggest that the consistent elevation and pattern of cTnT observed
n all participants during and after exercise likely reflects a
hysiologic as opposed to pathologic substrate. It seems unlikely
hat minor elevations in cTnT subsequent to endurance exercise
re due to myocardial necrosis (2). Rather, it is possible that
ost-exercise cTn release represents reversible cardiomyocyte mem-
rane damage that might reflect part of a remodeling process (2).
To test the effects of reversible myocardial ischemia, Kurz et al.
3) used a pre-commercial high-sensitivity cardiac troponin T
hsTnT) assay with a 5-fold lower detection limit than the
tandard assay. Single-photon emission computed tomography was
erformed to objectively document transient reversible ischemia.
he finding that hsTnT does not increase after reversible myocar-
ial ischemia supports the experimental results of Fishbein et al.
4), demonstrating that troponin release was restricted to irrevers-
ble myocyte necrosis. Moreover, intact cTnI and degradation
roducts were detectable by Western blot-direct serum assay
WB-DSA) in patients with acute ST-segment elevation myocar-
ial infarction (5). Metabolic inhibition of cardiomyocytes induces
arallel release of intact cTnT and cTnI and their degradation
roducts, starting only after onset of irreversible cardiomyocyte
amage (6). By contrast a recent study demonstrates that viable
ardiomyocytes release cTnI as an intact protein by a stretch-
elated mechanism mediated by integrins (7). Integrin stimulation
n cardiomyocytes does not result in degradation of cTnI into its
ragments (7). Accordingly, if post-exercise release of cTn repre-
ents reversible cardiomyocyte membrane damage, it is due to a
tretch-related mechanism (7) as opposed to metabolic stress or
schemia (3,4,6). However, it has been previously demonstrated
hat no relationship exists between post-exercise cTn release and a
tretch-related mechanism (8).
Therefore, it is possible that release of cTn represents irrevers-
ble damage that has been proposed either as pathognomic of
ardiac necrosis or might reflect part of a remodeling process
physiologic substrate) (1,9). To further understand exercise-
nduced cTn release, future work should use WB-DSA (5) to Hemonstrate degradation products representing irreversible cardi-
myocyte damage (3,4,6,7).
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e thank Drs. Koller and Schobersberger for their interest in our
tudy (1). The mechanism of release of cardiac troponin (cTn) in
pparently healthy individuals remains unclear (2). Our data
emonstrate that cTn might be released in all individuals after
rolonged exercise and have been confirmed by others (2). Recent
tudies using highly sensitive developmental assays demonstrate a
ormal distribution of cTn in apparently healthy populations (2,3).
herefore, it is likely that post-exercise release of cTn is due to a
hysiologic as opposed to a pathologic substrate. Conversely,
levations of cTnT above the 99th percentile of currently available
ommercial assays confer poor prognosis in general clinical popu-
ations (4).
Koller and Schobersberger suggest, on the basis of the work of
essel et al. (5), a potential physiologic mechanism responsible for
ost-exercise cTn release. Ventricular stretch induced by pro-
onged exercise might stimulate integrins located in the cellular
embrane that link the cytoskeleton to the extracellular matrix.
ntegrins could facilitate transport of the small (3% to 8%)
ytosolic fraction of cTn out of healthy cardiomyocytes (6).
owever, the careful interpretation of Western blotting performed
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t different cTn epitopes from those in the commercial immuno-
ssay is warranted, with in-depth investigation of the clinical
elevance of detecting low-weight cTn fractions (7).
Previous studies have unsuccessfully attempted to link ventric-
lar stretch assessed via B-type natriuretic peptide with exercise-
nduced cTn release (8). Other than our recent study, previous
ork is limited to pre- and post-exercise blood draws. As we have
hown, a single blood draw post-exercise does not provide a true
eflection of the release of cardiac biomarkers during exercise.
herefore, although previous studies are of interest, they do not
ully examine the relationship between exercise-induced cTn
elease and ventricular stretch. Accordingly, further work is re-
uired to examine all potential mechanisms of exercise-induced
Tn release, including the stimulation of integrins.
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